Get the Stockscreener App
5.13
0.39%
0.02
Nextcure Inc stock is traded at $5.13, with a volume of 22,202.
It is up +0.39% in the last 24 hours and up +4.27% over the past month.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
See More
Previous Close:
$5.11
Open:
$5.07
24h Volume:
22,202
Relative Volume:
0.09
Market Cap:
$13.73M
Revenue:
-
Net Income/Loss:
$-58.52M
P/E Ratio:
-2.4545
EPS:
-2.09
Net Cash Flow:
$-45.03M
1W Performance:
+0.29%
1M Performance:
+4.27%
6M Performance:
+609.64%
1Y Performance:
+224.68%
1-Day Range:
$5.03
$5.21
1-Week Range:
$4.94
$5.6299
52-Week Range:
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
Name
Nextcure Inc
Sector
Industry
Phone
240-399-4900
Address
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Compare NXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
5.13 | 14.08M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| Mar-05-21 | Upgrade | Truist | Hold → Buy |
| Jan-15-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-16-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-13-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-13-20 | Downgrade | SunTrust | Buy → Hold |
| Jun-01-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-01-20 | Downgrade | The Benchmark Company | Buy → Hold |
| May-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Mar-24-20 | Initiated | The Benchmark Company | Buy |
| Mar-02-20 | Initiated | ROTH Capital | Buy |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Dec-05-19 | Initiated | Needham | Buy |
| Nov-26-19 | Initiated | BTIG Research | Buy |
| Jul-09-19 | Initiated | BofA/Merrill | Buy |
| Jun-03-19 | Initiated | Morgan Stanley | Overweight |
| Jun-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Nextcure Inc Stock (NXTC) Latest News
Is NextCure Inc. meeting your algorithmic filter criteriaJuly 2025 Movers & Daily Stock Trend Reports - Newser
Using fundamentals and technicals on NextCure Inc.Quarterly Investment Review & Long-Term Safe Return Strategies - Newser
NextCure Inc. stock prediction for this weekJuly 2025 Retail & Verified Chart Pattern Trade Signals - Newser
Using economic indicators to assess NextCure Inc. potentialEarnings Risk Summary & Smart Swing Trading Alerts - Newser
Visualizing NextCure Inc. stock with heatmapsWeekly Trading Summary & AI Forecast Swing Trade Picks - Newser
Using R and stats models for NextCure Inc. forecastingGap Down & High Yield Equity Trading Tips - Newser
Real time pattern detection on NextCure Inc. stockWeekly Loss Report & Reliable Price Breakout Alerts - Newser
Ranking NextCure Inc. among high performing stocks via tools2025 Market Overview & Daily Price Action Insights - Newser
Real time alert setup for NextCure Inc. performanceGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Sector ETF performance correlation with NextCure Inc.Weekly Trading Summary & Risk Managed Investment Strategies - Newser
Backtesting results for NextCure Inc. trading strategiesMarket Weekly Review & Community Supported Trade Ideas - Newser
Market reaction to NextCure Inc.’s recent newsQuarterly Performance Summary & Risk Managed Trade Strategies - Newser
Risk vs reward if holding onto NextCure Inc.2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Can you recover from losses in NextCure Inc.Market Growth Report & Weekly Top Gainers Trade List - Newser
Recovery Signals Appearing in NextCure Inc. Charts2025 EndofYear Setup & High Return Trade Opportunity Guides - beatles.ru
Technical signs of recovery in NextCure Inc.Market Sentiment Report & Consistent Income Trade Recommendations - Newser
Price Clustering Detected in NextCure Inc. Stock2025 Technical Overview & Consistent Return Strategy Ideas - newsimpact.co.kr
How to monitor NextCure Inc. with trend dashboardsInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Will NextCure Inc. stock recover after recent dropShort Setup & Accurate Technical Buy Alerts - Newser
Is NextCure Inc. forming bullish engulfing patternsJuly 2025 PreEarnings & Daily Price Action Insights - thegnnews.com
How NextCure Inc. stock performs during market volatilitySwing Trade & Community Consensus Picks - Newser
NextCure Inc. Included in Top Momentum ScanJuly 2025 Weekly Recap & AI Forecast Swing Trade Picks - newsyoung.net
Does NextCure Inc. qualify in momentum factor screeningMarket Activity Report & Daily Profit Focused Stock Screening - Newser
Why NextCure Inc. stock attracts strong analyst attentionJuly 2025 Short Interest & Low Risk High Reward Ideas - Newser
NextCure Inc. Earnings Report Breakdown: What Investors Should Know2025 Key Highlights & Technical Pattern Based Signals - Newser
What makes NextCure Inc. stock price move sharplyJuly 2025 Movers & Weekly Breakout Opportunity Watchlist - thegnnews.com
NextCure Inc. Company Revenue and Profit Trends: A Deep DiveMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - Newser
Traders Watching For Reversal Pattern in NextCure Inc.Wall Street Watch & Daily Stock Trend Reports - sundaytimes.kr
Fibonacci Support Holding Strong in NextCure Inc.Index Update & Low Risk Investment Opportunities - kangso.co.kr
Nextcure Inc Stock (NXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):